Ultragenyx Pharmaceutical
RARE
RARE
220 hedge funds and large institutions have $6.01B invested in Ultragenyx Pharmaceutical in 2021 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 85 increasing their positions, 79 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
27% less call options, than puts
Call options by funds: $3.59M | Put options by funds: $4.9M
42% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 43
Holders
220
Holding in Top 10
–
Calls
$3.59M
Puts
$4.9M
Top Buyers
| 1 | +$190M | |
| 2 | +$41.5M | |
| 3 | +$41M | |
| 4 |
Alkeon Capital Management
New York
|
+$35.6M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$32.5M |
Top Sellers
| 1 | -$109M | |
| 2 | -$41.1M | |
| 3 | -$35.2M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$33.7M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$33.1M |